Read More Pharma Industry News Can Indian biosimilar makers dominate ophthalmology markets after Eylea patent expiries? With Eylea patents expiring, Indian biosimilar makers are eyeing global ophthalmology markets. Find out who’s leading and what’s next. byPallavi MadhirajuJuly 1, 2025